Trademark: 76568020
Status Date
Friday, April 15, 2016
Registration Number
3678147
Registration Date
Tuesday, September 8, 2009
Filing Date
Wednesday, December 31, 2003
Published for Opposition
Tuesday, September 30, 2008
Cancellation Date
Friday, April 15, 2016
1 (Based on Use in Commerce) (Based on 44(e)) Diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA, and cDNA clones for medical research and development use; (Based on 44(e)) Diagnostic assays and test kits for use in laboratory, medical research and chemical research and development; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, proteins and antibodies, and molecular arrays of biological material for medical research use
5 (Based on 44(e)) Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognose or predict diseases; prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins,antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies,and molecular arrays of biological material for clinical or medical use; diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA and cDNA clones for clinical use
42 (Based on Use in Commerce) (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology and genomics; (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of pharmacogenomics, toxicogenomics and personalized medicine; Evaluation of clinical trial progress, and drug monitoring and monitoring of patient health progression as it relates to experimental research
44 (Based on 44(e)) Diagnostic services, namely, diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors
Apr 15, 2016
Cancelled Sec. 8 (6-Yr)
Sep 8, 2009
Registered-Principal Register
Aug 3, 2009
1(B) Basis Deleted; Proceed To Registration
Jun 16, 2009
Notice Of Allowance Cancelled
Aug 3, 2009
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 3, 2009
Review Of Correspondence Complete
Jul 30, 2009
Teas Post Publication Amendment Received
Jun 17, 2009
Case Assigned To Intent To Use Paralegal
Jun 16, 2009
Teas Delete 1(B) Basis Received
Dec 23, 2008
Noa Mailed - Sou Required From Applicant
Sep 30, 2008
Published For Opposition
Sep 10, 2008
Notice Of Publication
Aug 28, 2008
Law Office Publication Review Completed
Aug 28, 2008
Approved For Pub - Principal Register
Aug 28, 2008
Examiners Amendment Mailed
Aug 27, 2008
Examiner's Amendment Entered
Aug 27, 2008
Examiners Amendment -Written
Aug 25, 2008
Previous Allowance Count Withdrawn
Jul 25, 2008
Withdrawn From Pub - Og Review Query
Jul 15, 2008
Law Office Publication Review Completed
Jul 14, 2008
Approved For Pub - Principal Register
Jul 14, 2008
Amendment From Applicant Entered
Jul 14, 2008
Correspondence Received In Law Office
Jul 7, 2008
Paper Received
Mar 19, 2008
Non-Final Action Mailed
Mar 18, 2008
Non-Final Action Written
Mar 18, 2008
Previous Allowance Count Withdrawn
Sep 21, 2007
Withdrawn From Pub - Og Review Query
Sep 20, 2007
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 20, 2007
Teas Change Of Owner Address Received
Sep 11, 2007
Law Office Publication Review Completed
Sep 11, 2007
Approved For Pub - Principal Register
Aug 31, 2007
Amendment From Applicant Entered
Aug 31, 2007
Correspondence Received In Law Office
Aug 22, 2007
Automatic Update Of Assignment Of Ownership
Aug 6, 2007
Paper Received
Apr 18, 2007
Priority Action Mailed
Apr 18, 2007
Priority Action Written
Feb 2, 2007
Non-Final Action Mailed
Feb 1, 2007
Non-Final Action Written
Jan 11, 2007
Amendment From Applicant Entered
Jan 11, 2007
Correspondence Received In Law Office
Jan 11, 2007
Assigned To Lie
Dec 8, 2006
Paper Received
Sep 18, 2006
Letter Of Suspension Mailed
Sep 15, 2006
Suspension Letter Written
Sep 15, 2006
Amendment From Applicant Entered
Sep 5, 2006
Correspondence Received In Law Office
Sep 5, 2006
Paper Received
Jun 20, 2006
Attorney Revoked And/Or Appointed
Jun 20, 2006
Teas Revoke/Appoint Attorney Received
Mar 13, 2006
Inquiry As To Suspension Mailed
Mar 12, 2006
Suspension Inquiry Written
Sep 12, 2005
Letter Of Suspension Mailed
Sep 9, 2005
Suspension Letter Written
Sep 9, 2005
Amendment From Applicant Entered
Aug 16, 2005
Correspondence Received In Law Office
Aug 16, 2005
Paper Received
Mar 23, 2005
Letter Of Suspension Mailed
Mar 23, 2005
Suspension Letter Written
Mar 23, 2005
Examiners Amendment -Written
Mar 14, 2005
Letter Of Suspension Mailed
Mar 13, 2005
Suspension Letter Written
Feb 23, 2005
Amendment From Applicant Entered
Jan 31, 2005
Correspondence Received In Law Office
Jan 31, 2005
Paper Received
Feb 3, 2005
Amendment From Applicant Entered
Aug 19, 2004
Unresponsive/Duplicate Paper Received
Aug 19, 2004
Fax Received
Aug 2, 2004
Non-Final Action Mailed
Jul 20, 2004
Assigned To Examiner
Jul 20, 2004
Assigned To Examiner
Jan 14, 2004
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
